Your browser doesn't support javascript.
loading
The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer.
Murphy, Alexander D; Morgan, Robert D; Clamp, Andrew R; Jayson, Gordon C.
Affiliation
  • Murphy AD; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK. alexander.murphy3@nhs.net.
  • Morgan RD; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
  • Clamp AR; Division of Cancer Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
  • Jayson GC; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
Br J Cancer ; 126(6): 851-864, 2022 04.
Article in En | MEDLINE | ID: mdl-34716396
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Vascular Endothelial Growth Factor A Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Vascular Endothelial Growth Factor A Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article Affiliation country: United kingdom